You are here

AbbVie

AbbVie’s Humira, Pfizer’s Lyrica dominate a year of TV ad spend with almost $500M total

Fierce Pharma

Mon, 09/12/16 - 05:09 pm

Abbvie Is One Of The Most 'Dislocated Names' In Pharma

Yahoo/Benzinga

Wed, 09/7/16 - 08:05 pm

AbbVie: Not Your Father’s Biotech Company?

Barron's

Fri, 09/2/16 - 10:28 pm

Why AbbVie Won't Pull A Galapagos On Ablynx

Seeking Alpha

Tue, 08/30/16 - 09:47 am

How Late-Stage Asset Rova-T Could Become a Leading Therapy

Market Realist

Fri, 08/26/16 - 09:56 am

small cell lung cancer

How AbbVie Expects Risankizumab to Be a Transformative Therapy

Market Realist

Wed, 08/24/16 - 10:40 am

Crohn's Disease

Top 5 Drug Stocks of 2016

Investopedia

Sun, 08/21/16 - 12:19 pm

Bristol-Myers Squibb

AbbVie Inc Humira: What are the Future Prospects?

Bidness, ETC

Sat, 08/20/16 - 01:55 pm

Will AbbVie bite? Decision time after Ablynx’s rheumatoid arthritis drug fails a key study

Endpoints

Tue, 08/9/16 - 10:46 pm

rheumatoid arthritis

AbbVie Inc, Amgen, Inc: Lengthy Legal Battle Over Humira Begins

Bidness, ETC

Mon, 08/8/16 - 10:03 am

Elliott Associates sues AbbVie over failed bid for Shire

Yahoo/Reuters

Sat, 08/6/16 - 01:11 pm

AbbVie Sues Amgen to Fend Off Copy of Blockbuster Humira

Yahoo/Bloomberg

Sat, 08/6/16 - 12:53 pm

rheumatoid arthritis

AbbVie: What Will Happen After Humira?

Seeking Alpha

Thu, 08/4/16 - 09:07 pm

AbbVie Inc: New Drugs May Overcome Humira Loss

Bidness, ETC

Mon, 08/1/16 - 03:56 pm

AbbVie profit and revenue beat expectations, raises 2016 guidance

Marketwatch

Fri, 07/29/16 - 11:35 am

AbbVie Receives U.S. FDA Approval of Once-Daily VIEKIRA XR™ (dasabuvir, ombitasvir, paritaprevir and ritonavir) for the Treatment of Genotype 1 Chronic Hepatitis C

Yahoo

Wed, 07/27/16 - 09:48 am

AbbVie and Bristol-Myers Squibb to collaborate on lung cancer clinical trial

Marketwatch

Mon, 07/25/16 - 10:55 am

Bristol-Myers Squibb

clinical trials

How Abbvie's Humira Undercuts The Drug Industry Price Defense

Forbes

Thu, 07/21/16 - 09:03 am

FDA panel to review Humira, Enbrel biosimilars this week

BioPharma Dive

Tue, 07/12/16 - 09:22 am

advisory panels

Inside AbbVie’s Plans to Target Multiple Myeloma and Acute Myeloid Leukemia Segments with Venclexta

Market Realist

Mon, 07/11/16 - 10:50 am

Multiple Myeloma

acute myeloid leukemia

Pages